Sigma Planning’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
SM
Sigma Planning's ATNM Position: Q4 2016 in Review
Sigma Planning sold out of Actinium Pharmaceuticals (ATNM) in Q4 2016, closing a stake of 333 shares — an estimated $14K sold.
Sigma Planning first reported a position in ATNM in Q3 2016 and held it in 1 quarter. The position peaked at $14K in Q3 2016. 30 funds tracked by Wall St. Rank hold ATNM as of Q4 2016.
- Sigma Planning reported no remaining Actinium Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Sigma Planning sold 333 Actinium Pharmaceuticals shares in Q4 2016, an estimated $14K.
- Sigma Planning first reported a position in Actinium Pharmaceuticals in Q3 2016 and held it in 1 quarter.
- Sigma Planning's Actinium Pharmaceuticals position peaked at $14K in Q3 2016.
- 30 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2016.
Based on Sigma Planning's 13F filing for Q4 2016, filed 23 Jan 2017.